Home > Insider Trading > Filing (0001209191-14-030386)

Filing Details

Accession Number:: 0001209191-14-030386
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-01 20:43:20
Reporting Period:: 2014-04-29

Filing Date:: 2014-05-01
Accepted Time:: 2014-05-01 19:43:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNTU	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
923421	John L Wilkerson	Elizabeth House, 9 Castle Street St Helier Y9 JE2 3RT		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2014-04-30	287,914	$0.00	5,093,820	No	4	P	Indirect	By Galen Partners V LP
Ordinary Shares	Acquisiton	2014-04-30	24,586	$0.00	434,978	No	4	P	Indirect	By Galen Partners International V LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Galen Partners V LP
No	4	P	Indirect	By Galen Partners International V LP

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Employee Stock Option (right to buy)	Acquisiton	2014-04-29	3,500	$0.00	3,500	$8.00
Ordinary Shares	Ordinary Share Warrants	Acquisiton	2014-04-30	287,914	$8.00	230,331	$0.00
Ordinary Shares	Ordinary Share Warrants	Acquisiton	2014-04-30	24,586	$8.00	19,669	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,500		2024-04-29	No	4	A	Direct
287,914	2014-07-24	2015-10-25	No	4	P	Indirect
24,586	2014-07-24	2015-10-25	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	150,704	Indirect	Galen Management, LLC

Footnotes

In connection with Quotient Limited's initial public offering, 287,914 units were purchased by Galen Partners V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one Ordinary Share and one warrant to purchase 0.8 of one Ordinary Share. The units currently trade on NASDAQ. The Ordinary Shares and warrants comprising the units will begin trading separately on May 24, 2014, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on July 24, 2014 and ending at 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
Consists solely of 5,093,820 ordinary shares held of record by Galen Partners V LP, 434,978 ordinary shares held of record by Galen Partners International V LP and 150,704 ordinary shares held of record by Galen Management, LLC (collectively, "Galen Partners"), as applicable. John Wilkerson along with David W. Jahns, and Zubeen Shroff exercise voting, investment and dispositive rights over the securities held of record by Galen Partners. Mr. Wilkerson disclaims beneficial ownership of these ordinary shares, except to the extent of his proportionate pecuniary interest in such shares.
In connection with Quotient Limited's initial public offering, 24,586 units were purchased by Galen Partners International V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one Ordinary Share and one warrant to purchase 0.8 of one Ordinary Share. The units currently trade on NASDAQ. The Ordinary Shares and warrants comprising the units will begin trading separately on May 24, 2014, at which time trading of the units will be suspended and the units will be de-listed. Each warrant will be exercisable during the period commencing on July 24, 2014 and ending at 5:30 p.m. on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
The option becomes exercisable in three equal annual installments beginning April 29, 2015.